Corporations need penalties that hurt

In the Los Angeles Times, Michael Hiltzik writes, “If you’re concerned about corporate crime, 2012 looked like a pretty successful year for the good guys.” The Thousand Oaks biotech giant Amgen paid $762 million in fines and penalties and pleaded guilty to a federal charge related to illegal marketing of its anemia drug Aranesp. Britain’s GlaxoSmithKline and Illinois-based Abbott Laboratories paid $3 billion and $1.5 billion in government penalties, respectively, in connection with their off-label promotions of blockbuster drugs. Glaxo’s was the biggest drug company settlement in history. To the companies, however, these big numbers are just chump change.

October 27, 2016 NRA Top Trump Funder National Rifle Association committees making independent campaign expenditures to oppose Democratic presidential nominee Hillary Clinton have spent more than $14 million on the race, surpassing the spending of the most active pro-Trump Super PAC. Acc... Read More >